机器人辅助根治性膀胱切除术与开放根治性膀胱切除术伤口相关并发症差异的评估
该回顾性研究纳入2013—2021年269例根治性膀胱切除术患者,比较机器人辅助根治性膀胱切除联合体内尿流改道(RARC-ICUD)、开放根治性膀胱切除(ORC)与机器人辅助根治性膀胱切除联合体外尿流改道(RARC-ECUD)的手术部位并发症。三组在30天(P<.001)和90天(P<.001)总手术部位并发症上差异有统计学意义,RARC-ICUD组发生手术部位并发症的患者最少(0.8%),ORC组为25.4%,RARC-ECUD组为29.2%。作者认为RARC-ICUD的手术部位并发症率低于ORC或RARC-ECUD。
要点
- RARC-ICUD组手术部位并发症发生率0.8%,低于ORC组25.4%和RARC-ECUD组29.2%。
- 三组30天和90天总手术部位并发症比较差异均有统计学意义(P<.001)。
- 作者认为微创入路可能降低手术部位并发症,尤其适用于高危患者。
核心结论
- 接受RARC-ICUD的患者手术部位并发症率低于接受ORC或RARC-ECUD的患者。
- 本研究提示手术部位并发症减少可能是微创入路的获益之一,尤其适用于根治性膀胱切除术后手术部位并发症高危患者。
研究设计与样本
- 回顾性审查本院膀胱癌数据库2013—2021年接受根治性膀胱切除术的患者。
- 共269例患者,按手术方式分为RARC-ICUD组127例(47.2%)、ORC组118例(43.7%)和RARC-ECUD组24例(8.9%)。
- 三组平均年龄分别为71.0岁、69.5岁和67.5岁。
- 在30天和90天两个时间点评估手术部位并发症。
主要发现
- RARC-ICUD组发生手术部位并发症的患者为0.8%,ORC组为25.4%,RARC-ECUD组为29.2%。
- 三组总手术部位并发症在30天(P<.001)和90天(P<.001)时间点比较差异均有统计学意义。
临床怎么用
- 作者认为手术部位并发症减少可能是微创入路的获益之一,尤其适用于根治性膀胱切除术后手术部位并发症高危患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) compared to open radical cystectomy (ORC) or RARC with extracorporeal urinary diversion (ECUD) would result in a decreased rate of surgical site complications. RARC has been shown to be non-inferior to ORC. Both RARC and ORC are complicated by a high rate of perioperative morbidity, including wound-related complications, which may be decreased by a robotic approach with intracorporeal diversion. METHODS: A retrospective review of our bladder cancer database for patients undergoing radical cystectomy from 2013-2021. Patients were stratified by surgical technique as RARC with ICUD vs ORC vs RARC with ECUD. Surgical site complications were measured at both 30- and 90-day intervals. RESULTS: Of the 269 patients, 127 (47.2%) had RARC with ICUD, 118 (43.7%) had ORC, and 24 (8.9%) had RARC with ECUD (mean ages 71.0, 69.5, and 67.5, respectively). A comparison of the 3 groups demonstrated statistical significance at both the 30-day (P <.001) and 90-day (P <.001) timeframes for total surgical site complications, with RARC with ICUD having the fewest amount of patients experiencing a surgical site complication (0.8%) followed by ORC (25.4%) and RARC with ECUD (29.2%). CONCLUSION: Overall, we observed lower surgical site complication rates among patients undergoing RARC with ICUD compared to patients who underwent ORC or RARC with ECUD. This study suggests that decreased surgical site complications may be one benefit of the minimally invasive approach, particularly in patients at high risk for surgical site complications after radical cystectomy.
引用
- Taber C, Lee B, Djang R, et al. Evaluating the Differences of Wound Related Complications in Robotically Assisted Radical Cystectomy vs Open Radical Cystectomy. Urology. 2024. PMID: 38852626. doi:10.1016/j.urology.2024.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。